Clinical Trials Browser

Phase 4 × Meropenem × 30 days × Clear all

NCT07590648 2026-05-15

E-STOP2

Phase 4 Not yet recruiting

Classical hematologyOther hematologic neoplasm

Neoplasms, Neutropenia, Hematologic Neoplasms, Febrile Neutropenia